Economics of the Pharmaceutical Industry

This page is under construction, please be patient as we develop it further

guaranteed profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research

Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development

Research often funded by public purse (universities) but profits go to industry.

Back to IP home